View EO 12866 Meeting 0938-AT72

Title: CY 2020 Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Medicare Part B (CMS-1715-P)

Agency/Subagency: 0938-HHS/CMS

Stage of Rulemaking: Proposed Rule Stage

Meeting Date/Time: 06/10/2019 03:00 PM

Requestor: Thorn Run Partners Requestor's Name: Andrea Maresca Requestor's Client: The Biosimilars Forum

Documents:

List of Documents
20190425_Methodological Memo and Overview of Biosimilar Shared Savings Program (1)
RFI on a Provider Shared Savings Model for Biosimilars in Medicare Part B 2019_05_20
20190429_BSF_Overview of Avalere Scores of Incentives for Biosimilar_FINAL OIRA
Implications of UnitedHealthcare Preferences
June 10 attachment
June 10 Meeting Attachment

Attendees:

List of Attendees		Participation
•	Andrew Self - OMB	Teleconference
•	Elyse Greenwald - OMB/OIRA	In Person
•	Marge Watchorn - CMS	Teleconference
•	Anna Bellantoni - OMB/HD	In Person
•	Gift Tee - CMS	Teleconference
•	Czift Tee - CMS	Teleconference
•	Alicia Swenson O'Brien - HHS	Teleconference
•	Jaime Hermansen - CMS	Teleconference
•	Mathias Gardner - OMB/HD	Teleconference
•	Elisabeth Daniel - OMB	In Person
•	Elliott Issac - CMS	Teleconference
•	Tiffany Fletcher - Sandoz	In Person
•	Joanna Young - Avalere Health	In Person
•	James Carey - Merck	In Person
•	Andrea Maresca - The Biosimilars Forum	In Person
•	Molly Burich - Boehringer-Ingelheim	In Person
•	Dara A. Corrigan - Fresenius Kabi	In Person
•	Juliana Reed - Pfizer	In Person
•	John Kraemer - Pfizer	In Person